Skip to Content

Notice

Manufacturer of Controlled Substances Registration: Chattem Chemicals, Inc.

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

ACTION:

Notice of registration.

SUMMARY:

Chattem Chemicals, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The DEA grants Chattem Chemicals, Inc. registration as a manufacturer of those controlled substances.

End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

By notice dated August 27, 2014, and published in the Federal Register on September 4, 2014, 79 FR 52764, Chattem Chemicals, Inc., 3801 St. Elmo Avenue, Chattanooga, Tennessee 37409, applied to be registered as a manufacturer of certain basic classes of controlled substances. No comments or objections were submitted to this notice.

The Drug Enforcement Administration (DEA) has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Chattem Chemicals, Inc. to manufacture the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company's maintenance of effective controls against diversion by inspecting and testing the company's physical security systems, verifying the company's compliance with state and local laws, and reviewing the company's background and history.

Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above-named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed:

Controlled substanceSchedule
Gamma Hydroxybutyric Acid (2010)I
4-Methoxyamphetamine (7411)I
Dihydromorphine (9145)I
Amphetamine (1100)II
Methamphetamine (1105)II
Lisdexamfetamine (1205)II
Methylphenidate (1724)II
Pentobarbital (2270)II
Codeine (9050)II
Dihydrocodeine (9120)II
Oxycodone (9143)II
Hydromorphone (9150)II
Hydrocodone (9193)II
Meperidine (9230)II
Meperidine intermediate-A (9232)II
Meperidine intermediate-B (9233)II
Meperidine intermediate-C (9234)II
Methadone (9250)II
Methadone intermediate (9254)II
Morphine (9300)II
Oripavine (9330)II
Thebaine (9333)II
Opium tincture (9630)II
Opium, powdered (9639)II
Opium, granulated (9640)II
Oxymorphone (9652)II
Noroxymorphone (9668)II
Alfentanil (9737)II
Remifentanil (9739)II
Sufentanil (9740)II
Tapentadol (9780)II
Fentanyl (9801)II

The company plans to manufacture the listed controlled substances in bulk for distribution and sale to its customers. Regarding (9640) the company plans to manufacture another controlled substance for sale to its customers.

Start Signature

Dated: January 9, 2015.

Joseph T. Rannazzisi,

Deputy Assistant Administrator.

End Signature End Supplemental Information

[FR Doc. 2015-01308 Filed 1-23-15; 8:45 am]

BILLING CODE 4410-09-P